Eric Miller appointed as Executive Director of global rare disease advocacy group – March 2020March 9, 2020Optio attends CHDI – February 2020, Palm Springs, USAFebruary 27, 2020Optio attends the Huntington Study Group annual meeting – November 2019, Sacramento, CANovember 27, 2019JP Morgan Healthcare Conference, January 2019; Optio Biopharma Solutions conducts neurodegenerative rare disease asset valuation due diligence and other activitiesJanuary 15, 2019The Huntington’s market heats up – observations as Optio attends the November 2018 HSG congress.November 11, 2018Optio attends Huntington’s Disease Society of America 33rd annual convention – Los Angeles, June 2018June 6, 2018Optio welcomes Ebo Dawson-Andoh; Executive Consultant, Pharma/Healthcare Survey Analyst – January 2018January 15, 2018Optio conducts social worker and caregiver focus group research at a neurological rare disease meeting – Chicago, IL.June 21, 2017Optio conducts business development interviews for a rare disease product valuation in conjunction with the 35th Annual J.P. Morgan Healthcare Conference.January 9, 2017Optio Biopharma Solutions attends the 23rd Annual Huntington’s Study Group Meeting and 10th Annual Clinical Research Symposium in Nashville, TN.November 2, 2016 Tweets by OptioBiopharma All new engagements start with a meeting. Let's Meet!